Interactive Investor International Plc

Interactive Investor International Plc

Interactive Investor International Plc

Angiotensin II (Ang II) is the active peptide in the renin-angiotensin system (RAS), which is known to regulate fluid balance, including blood pressure, and may be involved in cardiovascular disease. The peptide exerts its effects by binding to a receptor; there are four known Ang II receptor subtypes, though only two of known importance in adult humans and one is targeted for anti-hypertensive therapy. Upon Ang II binding, the receptor, which is a membrane protein, changes its conformation and becomes a scaffold for signaling molecules within the cell. The type of signaling and its downstream effects depends on the receptor.

G-proteins and Tyrosine Kinase Signaling

G-proteins switch between guanine nucleotide diphosphate (GDP) and triphosphate (GTP) as the energy of the phosphate bonds are utilized to activate second messengers, such as IP3. There are three subunits – alpha (a), beta (b), and gamma (g). There are also stimulatory (s), inhibitory (i), and PLC activating (q) types of Ga. It is known that Gaq and Gbg subunits are involved in Ang II receptor activation of tyrosine kinases.

Tyrosine phosphorylation activates PI3-kinase in cardiomyocytes inducing protein synthesis in the heart. An increase in intracellular calcium is evoked by IP3, resulting in activation of myosin light chain kinase and contraction in vascular smooth cells or secretion of aldosterone from cells in the adrenal cortex. Protein kinase C (PKC) is activated by DAG, also leading to phosphorylation of proteins involved in vasoconstriction and cell growth.